U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States
CDC. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR 2002;51 (No. RR-18).
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1
Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 2003;187:725-35.
Rapid testing and zidovudine treatment to prevent vertical transmission of HIV in unregistered parturients: A cost-effectiveness analysis
Stringer JS, Rouse DJ. Rapid testing and zidovudine treatment to prevent vertical transmission of HIV in unregistered parturients: a cost-effectiveness analysis. Obstet Gynecol 1999;94:34-40.